21 May 2013
Keywords: Russia, Investment, Drug-making capacity, AIPM
Article | 18 February 2011
According to the AIPM, these are only initial investments, which may significantly increase at the next stages of the companies& ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
18 February 2011
17 February 2011
20 May 2013
© 2013 thepharmaletter.com